Reuse 510(k)s Should Be Required For Class I Forceps - Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
FDA should remove the current exemption from premarket notification requirements for reprocessors of single use non-electric biopsy forceps, Boston Scientific maintains in a citizen petition filed by the agency Sept. 27.
You may also be interested in...
General Controls, Inspections Suffice For Reprocessed Class I Forceps - FDA
Process validation compliance and monitoring of manufacturing provide reasonable assurances that reprocessed single-use non-electric biopsy forceps are sterile, FDA argues in denying a Boston Scientific citizen petition.
General Controls, Inspections Suffice For Reprocessed Class I Forceps - FDA
Process validation compliance and monitoring of manufacturing provide reasonable assurances that reprocessed single-use non-electric biopsy forceps are sterile, FDA argues in denying a Boston Scientific citizen petition.
FDA's Premarket Policy For Device Reprocessors Questioned By Congressmen
FDA review standards for premarket applications submitted by reprocessors of single-use devices (SUDs) must be clarified to address the issue of one-time reuse versus multiple reuse, House Commerce Committee Chair Thomas Bliley (R-Va.) and Oversight and Investigations Subcommittee Chair Fred Upton (R-Mich.) maintain in a Nov. 1 letter to the agency.